Head-to-head · Cost-Efficiency Index
Gatlan vs Mirabel Meds
Two GLP-1 programs on the bench, scored on the same six factors. Here's how their real cost of ownership compares — and which one we'd start with.
Gatlan
Cost-first shoppers who want named clinical leadership (Dr. Robert Lufkin) over transparent per-dose pricing, which the site does not publish.
Visit GatlanMirabel Meds
Shoppers drawn to a premium-positioned brand who don't mind requesting pricing directly.
Visit Mirabel MedsThe verdict
Gatlan and Mirabel Meds tie on the Cost-Efficiency Index at 54/100, so neither wins outright on the numbers. For most shoppers we'd start with Gatlan (ranked #354, a hair above #360) — Cost-first shoppers who want named clinical leadership (Dr. Robert Lufkin) over transparent per-dose pricing, which the site does not publish. But Mirabel Meds is a genuine coin-flip alternative here.
Worth knowing either way: our overall #1 pick is CoreAge Rx (Cost-Efficiency Index 94/100 — the top of the ranking). See how it stacks up: CoreAge Rx vs Gatlan.
Factor by factor
Both providers scored on our six Cost-Efficiency Index factors. The stronger side on each row is marked in teal.
Normalized Cost/Month
Price Transparency
Nationwide Access
Formulation Options
Clinical Oversight
Contract Flexibility
Pricing, coverage & formulary
The disclosed facts behind the scores. Lower price wins its row (teal).
| Spec | Gatlan | Mirabel Meds |
|---|---|---|
| Cost-Efficiency Index | 54/100 | 54/100 |
| Semaglutide / mo | Not disclosed | Not disclosed |
| Tirzepatide / mo | $199/mo (starting dose, compounded) | Not disclosed |
| Semaglutide / yr (modeled) | — | — |
| Tirzepatide / yr (modeled) | $2,388 | — |
| Coverage | 44 states | All 50 states |
| Oral / sublingual | No | No |
| Brand-name access | Compounded only | Yes |
| Rank here | #354 | #360 |
Gatlan
54/100Where the value is
- Named Chief Medical Advisor with verifiable academic credentials — Dr. Robert Lufkin, UCLA/USC
- 44 states are listed by name in the footer, so coverage can be checked without starting sign-up
- A real 'From $199/mo' price point is published without requiring signup, even though it isn't broken out by drug or dose
The tradeoffs
- The '$199/mo' figure is a bare 'starting at' number — no dose, no named drug, and no indication of what happens to price at higher doses
- No LegitScript badge found on any page reached
Mirabel Meds
54/100Where the value is
- Claims LegitScript certification with a visible badge
- Nationwide coverage across all 50 states
- Offers a microdose GLP-1 tier alongside standard semaglutide/tirzepatide
The tradeoffs
- The originally-known domain (mirabelmeds.com) is a dead/expired deployment
- Zero pricing disclosed anywhere on the site
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Cost-Efficiency Index. Pricing, states and verification reflect each provider's public disclosures at last review; prices change — confirm on the provider's site. Not medical advice. See our disclosure.